Literature DB >> 17891281

Southern Cone Initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusional Chagas disease. Historical aspects, present situation, and perspectives.

João Carlos Pinto Dias1.   

Abstract

Created in 1991 by the governments of Argentina, Bolivia, Brazil, Chile, Paraguay, and Uruguay, the Southern Cone Initiative (SCI) has been extremely important for Chagas disease control in this region. Its basic objective was to reach the interruption of this disease, chiefly by means of the elimination of the principal vector Triatoma infestans and by the selection of safe donors in the regional blood banks. After a summarized historic of SCI, the text shows the advance of technical and operative activities, emphasizing some factors for the initiative success, as well as some difficulties and constraints. The future of SCI will depend of the continuity of the actions and of political priority. Scientific community has been highly responsible for this initiative and its maintenance. At the side of this, national and international efforts must be involved and reinforced to assure the accomplishment of the final targets of SCI. Very specially, the Pan American Health Organization has cooperated with the Initiative in all its moments and activities,being the most important catalytic and technical factor for SCI success.

Entities:  

Mesh:

Year:  2007        PMID: 17891281     DOI: 10.1590/s0074-02762007005000092

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  79 in total

1.  Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment.

Authors:  Denise da Gama Jaén Batista; Marcos Meuser Batista; Gabriel Melo de Oliveira; Patrícia Borges do Amaral; Joseli Lannes-Vieira; Constança Carvalho Britto; Angela Junqueira; Marli Maria Lima; Alvaro José Romanha; Policarpo Ademar Sales Junior; Chad E Stephens; David W Boykin; Maria de Nazaré Correia Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

2.  Triatomine infestation in Guatemala: spatial assessment after two rounds of vector control.

Authors:  Jennifer Manne; Jun Nakagawa; Yoichi Yamagata; Alexander Goehler; John S Brownstein; Marcia C Castro
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

Review 3.  Current concepts in immunoregulation and pathology of human Chagas disease.

Authors:  Walderez O Dutra; Kenneth J Gollob
Journal:  Curr Opin Infect Dis       Date:  2008-06       Impact factor: 4.915

4.  Sustainability of vector control strategies in the Gran Chaco Region: current challenges and possible approaches.

Authors:  Ricardo E Gürtler
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

5.  In vitro and in vivo biological effects of novel arylimidamide derivatives against Trypanosoma cruzi.

Authors:  Bruno Lisboa Timm; Patrícia Bernadino da Silva; Marcos Meuser Batista; Francisca Hildemagna Guedes da Silva; Cristiane França da Silva; Richard R Tidwell; Donald A Patrick; Susan Kilgore Jones; Stanislav A Bakunov; Svetlana M Bakunova; Maria de Nazaré C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

6.  Reframing critical needs in vector biology and management of vector-borne disease.

Authors:  Shirley Luckhart; Steven W Lindsay; Anthony A James; Thomas W Scott
Journal:  PLoS Negl Trop Dis       Date:  2010-02-23

7.  Immunogenic salivary proteins of Triatoma infestans: development of a recombinant antigen for the detection of low-level infestation of triatomines.

Authors:  Alexandra Schwarz; Stefan Helling; Nicolas Collin; Clarissa R Teixeira; Nora Medrano-Mercado; Jen C C Hume; Teresa C Assumpção; Katrin Marcus; Christian Stephan; Helmut E Meyer; José M C Ribeiro; Peter F Billingsley; Jesus G Valenzuela; Jeremy M Sternberg; Günter A Schaub
Journal:  PLoS Negl Trop Dis       Date:  2009-10-20

8.  Chagas cardiomyopathy in the context of the chronic disease transition.

Authors:  Alicia I Hidron; Robert H Gilman; Juan Justiniano; Anna J Blackstock; Carlos Lafuente; Walter Selum; Martiza Calderon; Manuela Verastegui; Lisbeth Ferrufino; Eduardo Valencia; Jeffrey A Tornheim; Seth O'Neal; Robert Comer; Gerson Galdos-Cardenas; Caryn Bern
Journal:  PLoS Negl Trop Dis       Date:  2010-05-18

9.  Chagas disease, migration and community settlement patterns in Arequipa, Peru.

Authors:  Angela M Bayer; Gabrielle C Hunter; Robert H Gilman; Juan G Cornejo Del Carpio; Cesar Naquira; Caryn Bern; Michael Z Levy
Journal:  PLoS Negl Trop Dis       Date:  2009-12-15

Review 10.  New, improved treatments for Chagas disease: from the R&D pipeline to the patients.

Authors:  Isabela Ribeiro; Ann-Marie Sevcsik; Fabiana Alves; Graciela Diap; Robert Don; Michael O Harhay; Shing Chang; Bernard Pecoul
Journal:  PLoS Negl Trop Dis       Date:  2009-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.